| |
|
|
|
Therapix Biosciences Ltd.  
|
|
1.68 0.15 (0.1%) |
11-15 16:00 |
|
Open: |
1.53 |
Pre close: |
1.53 |
Target:
|
2.90
|
|
High: |
1.68 |
Low: |
1.4 |
Resistance:
|
2.48
3.15
|
|
Volume: |
71,177 |
Market Cap: |
7M |
Support:
|
1.40
1.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.59
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
2.21 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
2.45 |
Stochastic Oscillator |
%K(14,3):
|
21.11  |
|
MA(250): |
3.32 |
%D(3): |
15.34 |
|
Average Volume(K) |
3-Month: |
8493
|
52-Week |
High:
|
8.95 |
|
10-Days: |
20608 |
Low: |
1.40 |
|
RSI |
RSI(14):
|
36.32 |
Change(%): |
-80.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.820 |
Return on Equity (ttm) |
-362.8 |
Shares Out. (M) |
3.51 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-111.5 |
Shares Float (M) |
2.78 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.08 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
155 |
|
Book Value (p.s.) |
-0.260 |
EBITDA (p.s.) |
-2.071 |
P/E |
-0.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.46 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.01 |
P/CF |
-0.90 |
|
|
|
|
|
|
